These findings collectively indicate that CRP influences osteoclast differentiation in a conformation-dependent manner, with mCRP (unlike the native molecule) playing a role in bone resorption in inflammatory conditions such as RA, implying that mCRP–RANKL interactions could be explored as therapeutic targets for osteoclast modulation in RA [23]. Here, TNFSF11 is linked to rheumatoid arthritis.